Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Effects of a Thermogenic Dietary Supplement on Metabolic, Hemodynamic, and Mood Responses
NCT03678116 · View on ClinicalTrials.gov ↗
Study Summary
This a randomized, double blind, placebo controlled, crossover design study which measures the effect of an available thermogenic dietary supplement on resting energy expenditure (REE), blood pressure and heart rate, and mood changes in moderate caffeine consumers. Participants will complete baseline measurements then ingest one of three pills. Once the pill is ingested, subjects will complete four REEs along with heart rate and blood pressure and appropriate questionnaires. Participants will return two more times, each after a one week washout period, and complete the same protocol with the remaining supplements.
Conditions Studied
Interventions
- DRUG Sugar Pill (placebo)
- DIETARY_SUPPLEMENT Caffeine (plus Teacrine and Cayenne)
- DIETARY_SUPPLEMENT Caffeine (plus Teacrine)
Study Locations (1)
Texas
- UMHB Human Performance Lab — Belton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-07-23 |
| Est. Completion | 2018-10-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03678116
The ClinicalTrials.gov registry entry for NCT03678116 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mary Hardin-Baylor, which has 3 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 4 conditions, with Blood Pressure appearing as the primary indexed condition, and to 3 interventions — of which Sugar Pill (placebo) is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03678116 reports 1 study location spanning 1 distinct geographic area — top geographies include Texas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03678116 about?
NCT03678116 is a clinical study titled "Effects of a Thermogenic Dietary Supplement on Metabolic, Hemodynamic, and Mood Responses". This a randomized, double blind, placebo controlled, crossover design study which measures the effect of an available thermogenic dietary supplement on resting energy expenditure (REE), blood pressure and heart rate, and mood changes in moderate caffeine consumers. Participants will complete baselin...
What is the current status of trial NCT03678116?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-07-23. Estimated completion is 2018-10-31.
What conditions does trial NCT03678116 study?
This clinical trial studies the following conditions: Blood Pressure, Mood, Energy Metabolism, Heart Rate. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT03678116?
The interventions under investigation include: Sugar Pill (placebo) (DRUG), Caffeine (plus Teacrine and Cayenne) (DIETARY_SUPPLEMENT), Caffeine (plus Teacrine) (DIETARY_SUPPLEMENT). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT03678116?
This trial is sponsored by University of Mary Hardin-Baylor, which has 3 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03678116 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.